Caterna | Updates

By Michael Scherrer

Caterna in Practices’ Everyday Life - What Ophthalmologists and Orthoptists Have to Say


Dear Companists,

Our core business in recent years has been the acquisition of new ophthalmological practices: to intensify the cooperation with orthoptists, to raise awareness of Caterna and the Caterna technology, to answer questions, and to build trust in this digital solution. Today we can say that this work has paid off. Whenever we go to trade fairs, ophthalmologists and orthoptists have often heard of Caterna.

We are actively cooperating with more than 300 ophthalmological practices all over Germany and new ones are added weekly. This gives us a good basis for expanding our B2C marketing activities.

To give you Companists an insight into how Caterna works in practice, we talked to some of our long-standing partners.


Good experiences with children and adolescents

An orthoptist from an ophthalmologist's practice in northern Germany* reports that, with a few exceptions, an average improvement in visual acuity of 30 to 50% could be observed in children between the ages of four and twelve after Caterna therapy. She has been treating patients with Caterna Vision Training since 2012 and has gained a lot of experience during this period.

This not only for children but also for adolescents and adults, for whom the use of Caterna has often improved visual acuity. "We are very happy that we can prescribe Caterna Vision Training in addition to occlusion. In most cases, the children experienced a significant increase in visual acuity after only six weeks and were even more motivated to continue with the visual exercises.


Caterna as an effective digital solution

Although she was skeptical at first, Dr. med. Ingrid Wagner, specialist for ophthalmology with practices in Oranienburg and Templin, was quickly convinced of Caterna. The results of the therapy, she reports, have clearly exceeded expectations. For 80-90% of the children there was a significant improvement in vision within 3 to 4 months. It is also particularly helpful for older children who were diagnosed late or where occlusion did not produce the desired results.

Since occlusion therapy alone becomes difficult after the age of 6, the Caterna Vision Training is a good combination to successfully treat amblyopia. Accordingly, she concludes: "This program is a very innovative therapy that is in line with the times. Where usually only occlusion therapy (covering the better eye so that the worse eye learns to see) is used, the combination of occlusion with Caterna is significantly more effective".

We also try to make daily practice life as easy as possible for ophthalmologists and orthoptists. From letters of recommendation and cost estimates to filling out order forms and selective contracts with health insurance companies, our customer service staff provide doctors and orthoptists with advice and assistance with the aim of reducing the administrative costs for the practices in the best possible way. They can also monitor therapy adherence quickly and intervene in a supportive manner if necessary by means of digital therapy monitoring via a protected practitioner account.


Best greetings,

Michael Scherrer

* If the interviewees wish to remain anonymous, we naturally respect this. If you have specific questions, however, we will gladly establish contact.


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 188,800


€ 576

Average Investment

10.59 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Caterna.
Already registered?    Log in